Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The applications of pharmacogenomics to neurological disorders.

Current molecular medicine - 1 Jan 2014

Gilman C, McSweeney C, Mao Y

Abstract excerpt

The most common neurological disorders, including neurodegenerative diseases and psychiatric disorders, have received recent attention with regards to pharmacogenomics and personalized medicine. Here, we will focus on a neglected neurodegenerative disorder, cerebral ischemic stroke (CIS), and highlight recent advances in two disorders, Parkinson's disease (PD) and Alzheimer's diseases (AD), that possess both...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alzheimer Disease
Share to Brain Ischemia
Share to Genome-Wide Association Study

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Nervous System Diseases

Share to Parkinson Disease

Share to Pharmacogenetics

Share to Precision Medicine

Share to Stroke

Source

Identifiers

PMID: 25109797
DOI: 10.2174/1566524014666140811115900

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The applications of pharmacogenomics to neurological disorders.PMID 25109797Read ↗

Identification of Shared Genes Between Ischemic Stroke and Parkinson's Disease Using Genome-Wide Association StudiesSemantic proximity Read ↗

Central nervous system genomics.Semantic proximity Read ↗

Towards precision medicine in ischemic stroke and transient ischemic attack.Semantic proximity Read ↗

Prioritization of Drug Targets for Neurodegenerative Diseases by Integrating Genetic and Proteomic Data From Brain and BloodSemantic proximity Read ↗

Pharmacogenomics in neurology: current state and future steps.Semantic proximity Read ↗

An update on the role of ferroptosis in ischemic stroke: from molecular pathways to NeuroprotectionSemantic proximity Read ↗

Next-generation neurotherapeutics: nanotechnology, immunotherapy, and gene editing for neurodegenerative diseasesSemantic proximity Read ↗

Angiotensin‐converting enzymes as druggable features of psychiatric and neurodegenerative disordersSemantic proximity Read ↗

A guide to senolytic intervention in neurodegenerative diseaseSemantic proximity Read ↗

Mechanisms of Parkinson’s disease-related proteins in mediating secondary brain damage after cerebral ischemiaSemantic proximity Read ↗

Untargeted metabolomics unveils critical metabolic signatures in novel phenotypes of acute ischemic stroke.Semantic proximity Read ↗

Pharmacogenomics and therapeutic strategies for dementiaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.